Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022)

Spero Therapeutics posted quarterly Preferred Shares of $2000.0 for Q2 2022, down 33.33% year-on-year from $3000.0 in Q2 2021, and down 33.33% on a QoQ basis from $3000.0 in Q1 2022.

Spero Therapeutics (SPRO) has 3 years of Preferred Shares data on file, last reported at $2000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Preferred Shares fell 33.33% year-over-year to $2000.0; the trailing twelve-month figure through Jun 2022 stood at $2000.0 (down 33.33% YoY), and the FY2021 full-year result was $3000.0, changed 0.0% from the prior year.
  • Preferred Shares for Q2 2022 stood at $2000.0, down from $3000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $3000.0 in Q3 2020 and bottomed at $2000.0 in Q2 2022.
  • The 3-year median for Preferred Shares is $3000.0 (2020), against an average of $2875.0.
  • The widest annual swing landed in 2021, when Preferred Shares changed 0.0%; it then tumbled 33.33% in 2022.
  • A 3-year view of Preferred Shares shows it stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then tumbled by 33.33% to $2000.0 in 2022.
  • The last three Preferred Shares figures came in at $2000.0 (Q2 2022), $3000.0 (Q1 2022), and $3000.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Spero Therapeutics 162.39 Mn 106.26 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 2,000.00
Mar 31, 2022 3,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 3,000.00
Mar 31, 2021 3,000.00
Dec 31, 2020 3,000.00
Sep 30, 2020 3,000.00